A vibrating vest may help children with damaged lungs breathe easier
NCT ID NCT07722364
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial tests whether a special vibrating vest, worn around the chest, can improve lung function in children aged 6 to 12 with non-cystic fibrosis bronchiectasis — a condition where the airways are permanently widened and clogged with mucus. The vest shakes the chest at high frequency to loosen mucus, which may help children breathe better. Researchers will compare the vest to standard chest physiotherapy by measuring changes in lung function and exercise capacity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a vibrating vest (high-frequency chest wall oscillation) that shakes the chest to loosen mucus
- What this could lead to
- If it works, this could offer a more effective and easier way to clear mucus and improve breathing in children with bronchiectasis.
- What could go wrong
- This is a small, early-stage trial with only 60 children, so results may not apply to everyone. The vest may not work better than standard physiotherapy and could cause discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
pediatric hospital, Assiut university
Asyut, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic drug delay dangerous lung Flare-Ups?
- Inhaled experimental drug targets tough lung infections
- New drug trial aims to tame chronic lung infections
- Scientists develop risk score to forecast bronchiectasis attacks
- 500 patients to test if daily azithromycin keeps bronchiectasis attacks at bay
- New model may help classify bronchiectasis types